Who has invested in Neurogastrx?

5AM Ventures, OrbiMed Advisors, venBio Partners, Vivo Capital are named among the investors backing Neurogastrx.

Neurogastrx Funding: $105M Raised, Series B (2021)

Neurogastrx funding overview

Neurogastrx is based in Woburn, Massachusetts. Neurogastrx has raised $105M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for Neurogastrx runs through 2021; nothing later has been disclosed. Investors on record include 5AM Ventures, OrbiMed Advisors, venBio Partners, Vivo Capital. 4 distinct backers are named across the disclosed rounds.

Neurogastrx at a glance

Total raised: $105M
Latest round: Series B
Latest round date: August 2021
Headquarters: Woburn, Massachusetts
Notable investors: 5AM Ventures, OrbiMed Advisors, venBio Partners, Vivo Capital

Frequently asked about Neurogastrx funding

How much has Neurogastrx raised?: Neurogastrx has raised $105M in total disclosed funding across the rounds on record.
Who has invested in Neurogastrx?: 5AM Ventures, OrbiMed Advisors, venBio Partners, Vivo Capital are named among the investors backing Neurogastrx.
What was the latest Neurogastrx funding round?: The most recent disclosed round is a Series B, announced in August 2021.
Where is Neurogastrx based?: Neurogastrx is based in Woburn, Massachusetts.
When did Neurogastrx last raise?: The last disclosed Neurogastrx round closed in August 2021 at Series B.

Round data for Neurogastrx is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Woburn and backer lists below.

Neurogastrx Funding: $105M Raised, Series B (2021)

Neurogastrx funding overview

Neurogastrx at a glance

Frequently asked about Neurogastrx funding

Companies related to Neurogastrx (36)

Browse related funding lists (6)